Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care

Cabré, Joan-Josep; Martín, Francisco; Costa, Bernardo; Piñol, Josep L.; Llor, Josep L.; Ortega, Yolanda; Basora, Josep; Baldrich, Marta; Solà, Rosa; Daniel, Jordi; Hernández, Josep Ma; Saumell, Judit; Bladé, Jordi; Sagarra, Ramon; Basora, Teresa; Montañés, Dolors; Frigola, Joan L.; Donado-Mazarrón, Angel; García-Vidal, Maria Teresa; Sánchez-Oro, Isabel
January 2008
BMC Public Health;2008, Vol. 8 Issue 1, p251
Academic Journal
To estimate the prevalence of metabolic syndrome (MS) in a population receiving attention in primary care centers (PCC) we selected a random cohort of ostensibly normal subjects from the registers of 5 basic-health area (BHA) PCC. Diagnosis of MS was with the WHO, NCEP and IDF criteria. Variables recorded were: socio-demographic data, CVD risk factors including lipids, obesity, diabetes, blood pressure and smoking habit and a glucose tolerance test outcome. Of the 720 individuals selected (age 60.3 ± 11.5 years), 431 were female, 352 hypertensive, 142 diabetic, 233 pre-diabetic, 285 obese, 209 dyslipemic and 106 smokers. CVD risk according to the Framingham and REGICOR calculation was 13.8 ± 10% and 8.8 ± 9.8%, respectively. Using the WHO, NCEP and IDF criteria, MS was diagnosed in 166, 210 and 252 subjects, respectively and the relative risk of CVD complications in MS subjects was 2.56. Logistic regression analysis indicated that the MS components (WHO set), the MS components (IDF set) and the female gender had an increased odds ratio for CVD of 3.48 (95CI%: 2.26-5.37), 2.28 (95%CI: 1.84-4.90) and 2.26 (95%CI: 1.48-3.47), respectively. We conclude that MS and concomitant CVD risk is high in ostensibly normal population attending primary care clinics, and this would necessarily impinge on resource allocation in primary care.


Related Articles

  • METABOLIC SYNDROME, INFLAMMATORY MARKERS AND CARDIOVASCULAR RISK IN PATIENTS WITH VARIOUS DEGREES OF GLUCOSE TOLERANCE. Drăguţ, Ramona Maria; Rusu, Emilia; Nan, Raluca; Rusu, Florin; Enache, Georgiana; Grosu, Larisa; Popescu, Horaţiu; Posea, Mihaela; Grosu, Irina; Costache, Adrian; Homencovschi, Corina; Radulian, Gabriela // Internal Medicine / Medicina Interna;feb2015, Vol. 12 Issue 1, p13 

    The objective of this study was to evaluate cardiovascular risk in patients with metabolic syndrome and to assess the relationship between inflammatory markers, represented by adipokines, and cardiovascular risk in these patients. Material and methods. This cross-sectional and observational...

  • Nutrapharmacology of Tocotrienols for Metabolic Syndrome. Weng-Yew, Wong; Brown, Lindsay // Current Pharmaceutical Design;7/11/2011, Vol. 17 Issue 21, p2206 

    Metabolic syndrome is defined as a set of health risk factors that are associated with an increased chance of cardiovascular diseases and type 2 diabetes. These include abdominal obesity, hyperglycemia, impaired glucose tolerance, dyslipidemia, and hypertension. Interventions in metabolic...

  • Plasma Glucose Within the Normal Range Is Not Associated With Carotid Atherosclerosis. Bonora, Enzo; Kiechl, Stefan // Diabetes Care;Aug99, Vol. 22 Issue 8, p1339 

    Covers information on a study which assessed the association of glucose intolerance with an increased risk of cardiovascular disease. Main clinical and biochemical characteristics of the cohort study at baseline; Simple and partial correlations between glucose parameters and candidate risk...

  • Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria. Di Pino, Antonino; Scicali, Roberto; Calanna, Salvatore; Urbano, Francesca; Mantegna, Concetta; Rabuazzo, Agata Maria; Purrello, Francesco; Piro, Salvatore // Diabetes Care;May2014, Vol. 37 Issue 5, p1447 

    OBJECTIVE We investigated the cardiovascular risk pro le in subjects with prediabetes and new-onset type 2 diabetes identified by glycated hemoglobin A1c (HbA1c) according to the new American Diabetes Association criteria. RESEARCH DESIGN AND METHODS Arterial stiffness, intima-media thickness...

  • Impaired Fasting Glucose Is Not a Risk Factor for Cardiovascular Mortality. Weitzman, Simon // Diabetes Care;Dec99, Vol. 22 Issue 12, p2104 

    Comments on a study which showed that impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for cardiovascular disease. Highlights of the results; Role of fasting glucose on cardiovascular mortality; Limitations of the study.

  • IGT ups risk for abnormal retinal vascular reactivity, CVD. Costa, Samantha; Schoen, John; Taliercio, Adam // Endocrine Today;Sep2012, Vol. 10 Issue 9, p32 

    The article reports on a study which found a link between impaired glucose tolerance and microvascular and macrovascular function, as well as a direct association between retinal microcirculatory changes and established plasma markers for cardiovascular disease.

  • Impaired Glucose Tolerance. Perry, R. Clark; Baron, Alain D. // Diabetes Care;Jun99, Vol. 22 Issue 6, p883 

    Questions why impaired glucose tolerance is not a disease. Disparity between impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) as risk factors for cardiovascular disease; Reference to study by Tominaga et al. on dysglycemic macroangiopathy; Need for the use of the oral glucose...

  • Influence of heart rate at rest for predicting the metabolic syndrome in older Chinese adults. ó Hartaigh, Bríain; Jiang, Chao; Bosch, Jos; Zhang, Wei; Cheng, Kar; Lam, Tai; Thomas, G. // Acta Diabetologica;Jun2013, Vol. 50 Issue 3, p325 

    The aim of this study was to examine the relationship between seated resting heart rate and the metabolic syndrome (MetS) among older residents of Guangzhou, South China. A total of 30,519 older participants (≥50 years) from the Guangzhou Biobank Cohort Study were stratified into quartiles...

  • Factor Structure of Indices of the Second Derivative of the Finger Photoplethysmogram with Metabolic Components and Other Cardiovascular Risk Indicators. Kawada, Tomoyuki; Otsuka, Toshiaki // Diabetes & Metabolism Journal;Feb2013, Vol. 37 Issue 1, p40 

    Background: The second derivative of the finger photoplethysmogram (SDPTG) is an indicator of arterial stiffness. The present study was conducted to clarify the factor structure of indices of the SDPTG in combination with components of the metabolic syndrome (MetS), to elucidate the significance...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics